The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Proteolytic Processing of Nlrp1b Is Required for Inflammasome Activity
Open accessAbstract
Nlrp1b is a NOD-like receptor that detects the catalytic activity of anthrax lethal toxin and subsequently co-oligomerizes into a pro-caspase-1 activation platform known as an inflammasome. Nlrp1b has two domains that promote oligomerization: a NACHT domain, which is a member of the AAA+ ATPase family, and a poorly characterized Function to Find Domain (FIIND). Here we demonstrate that proteolytic processing within the FIIND generates N-terminal and C-terminal cleavage products of Nlrp1b that remain associated in both the auto-inhibited state and in the activated state after cells have been treated with lethal toxin. Functional significance of cleavage was suggested by the finding that mutations that block processing of Nlrp1b also prevent the ability of Nlrp1b to activate pro-caspase-1. By using an uncleaved mutant of Nlrp1b, we established the importance of cleavage by inserting a heterologous TEV protease site into the FIIND and demonstrating that TEV protease processed this site and induced inflammasome activity. Proteolysis of Nlrp1b was shown to be required for the assembly of a functional inflammasome: a mutation within the FIIND that abolished cleavage had no effect on self-association of a FIIND-CARD fragment, but did reduce the recruitment of pro-caspase-1. Our work indicates that a post-translational modification enables Nlrp1b to function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D. R., Latz, E., & Fitzgerald, K. A. (2009) · Nature · doi:10.1038/nature07725 · Cited by 2,627
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA
Fernandes-Alnemri, T., Yu, J.-W., Datta, P., Wu, J., & Alnemri, E. S. (2009) · Nature · doi:10.1038/nature07710 · Cited by 1,831 · cited 1×
“Inflammasomes are multi-protein complexes that facilitate the activation of pro-caspase-1 in response to pathogen associated molecular patterns (PAMPS) or endogenous danger associated molecular patterns (DAMPS). A common feature of inflammasomes is that they recruit multiple copies of pro-caspase-1, which allows auto-…”
BackgroundBauernfeind, F., Bartok, E., Rieger, A., Franchi, L., Núñez, G., & Hornung, V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100613 · Cited by 617
Cited by
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Regulation of inflammasome activation
Man, S. M., & Kanneganti, T. (2015) · Immunological Reviews · doi:10.1111/imr.12296 · Cited by 1,064
The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation
Sharma, D., & Kanneganti, T.-D. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201602089 · Cited by 728
Role of pyroptosis in inflammation and cancer
Wei, X., Xie, F., Zhou, X., Wu, Y., Yan, H., Liu, T., Huang, J., Wang, F., Zhou, F., & Zhang, L. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00905-x · Cited by 699
Emerging Activators and Regulators of Inflammasomes and Pyroptosis
Xue, Y., Enosi Tuipulotu, D., Tan, W. H., Kay, C., & Man, S. M. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.09.005 · Cited by 509
Mechanisms of inflammasome activation: recent advances and novel insights
Vanaja, S. K., Rathinam, V. A. K., & Fitzgerald, K. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.12.009 · Cited by 499
Inflammasome activation and assembly at a glance
Malik, A., & Kanneganti, T.-D. (2017) · Journal of Cell Science · doi:10.1242/jcs.207365 · Cited by 449
Recognition of Bacteria by Inflammasomes
von Moltke, J., Ayres, J. S., Kofoed, E. M., Chavarría-Smith, J., & Vance, R. E. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095944 · Cited by 421
Mechanisms of NOD-like Receptor-Associated Inflammasome Activation
Wen, H., Miao, E. A., & Ting, J. P.-Y. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.037 · Cited by 415
Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes
Sandstrom, A., Mitchell, P. S., Goers, L., Mu, E. W., Lesser, C. F., & Vance, R. E. (2019) · Science · doi:10.1126/science.aau1330 · Cited by 375
NOD-Like Receptors: Versatile Cytosolic Sentinels
Motta, V., Soares, F., Sun, T., & Philpott, D. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00009.2014 · Cited by 353
DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia
Johnson, D. C., Taabazuing, C. Y., Okondo, M. C., Chui, A. J., Rao, S. D., Brown, F. C., Reed, C., Peguero, E., de Stanchina, E., Kentsis, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0082-y · Cited by 350
Functions of NOD-Like Receptors in Human Diseases
Zhong, Y., Kinio, A., & Saleh, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00333 · Cited by 317
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Man, S. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0054-1 · Cited by 302
N-terminal degradation activates the NLRP1B inflammasome
Chui, A. J., Okondo, M. C., Rao, S. D., Gai, K., Griswold, A. R., Johnson, D. C., Ball, D. P., Taabazuing, C. Y., Orth, E. L., Vittimberga, B. A., et al. (2019) · Science · doi:10.1126/science.aau1208 · Cited by 298
NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice
Kovarova, M., Hesker, P. R., Jania, L., Nguyen, M., Snouwaert, J. N., Xiang, Z., Lommatzsch, S. E., Huang, M. T., Ting, J. P.-Y., & Koller, B. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201065 · Cited by 271
Multiple cathepsins promote pro-IL-1β synthesis and NLRP3-mediated IL-1β activation
Orlowski, G. M., Colbert, J. D., Sharma, S., Bogyo, M., Robertson, S. A., & Rock, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500509 · Cited by 268
“Abbreviations used in this article: CC, cholesterol crystal; CHX, cycloheximide; dAdT, poly(deoxyadenylic-deoxythymidylic) acid; LDH, lactate dehydrogenase; LLOMe, Leu-Leu-OMe; LMD, lysosomal membrane disruption; LRR, leucine-rich repeat; NLRP3, NOD-like receptor containing a pyrin domain 3; PM, peritoneal macrophage;…”
BackgroundInfluentialFinger, J. N., Lich, J. D., Dare, L. C., Cook, M. N., Brown, K. K., Duraiswami, C., Bertin, J. J., & Gough, P. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.378323 · Cited by 256
Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
Govindarajan, V., de Rivero Vaccari, J. P., & Keane, R. W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01944-9 · Cited by 110
Oxidized thioredoxin-1 restrains the NLRP1 inflammasome
(2022) · doi:10.1126/sciimmunol.abm7200 · Cited by 53
Metadata
- Authors
- Frew, B. C., Joag, V. R., & Mogridge, J.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-19
- Volume
- 8
- Issue
- 4
- Pages
- e1002659
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2088941584
- Cited by
- 162
- References
- 6
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.